What is Medline Inc. Class A Common Stock (MDLN)?
Medline Inc. Class A Common Stock trades as MDLN on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-11-03.
Is MDLN in a Closelooknet index?
Not currently — Medline Inc. Class A Common Stock is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-03.
What is Medline Inc. Class A Common Stock's Closelooknet composite score?
45 out of 100, with momentum 18, quality 33 and valuation 39 sub-scores, as of 2026-11-03. Scores are Closelooknet's own research readings, not ratings or investment advice.
How does Medline Inc. Class A Common Stock trade when bond yields rise?
Over the past year Medline Inc. Class A Common Stock had a beta of 0.48 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 42% of US names. On the 9 sessions in which long bonds fell most it moved −1.75% on average, against −0.74% for the S&P 500. As of 2026-11-02; The "How it trades on rate days" block on this page carries the lines.
What does Medline Inc. Class A Common Stock do?
Medline makes medical and surgical products used across hospitals, surgery centres, physician offices, post-acute sites and nursing homes in the United States and abroad. It runs two segments: Medline Brand, which manufactures surgical solutions, front-line patient care items and laboratory and diagnostic products, and Supply Chain Solutions, which distributes third-party brands and runs logistics and inventory services for care providers. It is based in Northfield, United States. Closelooknet's peer group here is Healthcare names listed in the US, drawn together simply because they share sector and country: argenx, Medpace, BeiGene, Globus Medical, Regeneron, Veeva Systems, Vertex Pharmaceuticals and Corcept Therapeutics. The market also names Cardinal Health as a comparable distributor of medical supplies. (Company snapshot of 2026-09-17.)
Where does Medline Inc. Class A Common Stock sit in the AI build-out?
Medline holds no seat in Rubin or Halo, the diary's two build-out indices, because its products are hospital and surgical supplies rather than compute infrastructure. In our universe it sits in the Healthcare sleeve, grouped by sector and country rather than by any layer of the AI stack. Medline carries a Closelooknet score with valuation as its strongest module and momentum as its weakest; it holds no seat in Rubin or Halo and no quotes appear in the diary's editions yet. (Company snapshot of 2026-09-17.)
Does Medline Inc. Class A Common Stock pay a dividend?
No cash distribution shows in Medline Inc. Class A Common Stock’s price series over the last three years. In fiscal 2025 the company bought back 2.00 bn USD of its own shares, 154% of that year’s free cash flow. The share count rose 3.2% over the fiscal year. As of 2026-11-02; the "Dividends and capital return" block on this page carries the lines.
What has Wall Street done on Medline Inc. Class A Common Stock recently?
The most recent analyst action on Medline Inc. Class A Common Stock on the Closelooknet wire is a price target by UBS on 2026-09-25 (target 43 from 45). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.
What does this page show?
A live price chart with SMA overlays and drawing tools for MDLN, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.